Trials / Completed
CompletedNCT07274800
Adjuvant Ultra-Hypofractionated vs Hypofractionated Radiotherapy for Early Breast Cancer
Adjuvant Ultra Hypofractionation Radiotherapy Versus Hypofractionation Radiotherapy in Treatment of Early Invasive Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
breast-conserving surgery. One group receives ultra-hypofractionated radiotherapy (26 Gy in 5 sessions over 1 week), while the other group receives hypofractionated radiotherapy (40 Gy in 15 sessions over 3 weeks). The study aims to compare skin toxicity, cosmetic outcomes, and local cancer control between thetwo schedules . Participants are followed during and after radiotherapy for up to 24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Adjuvant Ultra hypofractionation radiotherapy | Adjuvant external beam radiotherapy after breast-conserving surgery Total dose: 26 Gy delivered in 5 fractions over 1 week 3D conformal radiotherapy technique without breath-hold Daily fractionation, whole breast irradiation |
| RADIATION | Adjuvant Hypofarctionated radiotherapy | Adjuvant external beam radiotherapy after breast-conserving surgery Total dose: 40 Gy delivered in 15 fractions over 3 week 3D conformal radiotherapy technique without breath-hold Daily fractionation, whole breast irradiation |
Timeline
- Start date
- 2023-11-27
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
- First posted
- 2025-12-10
- Last updated
- 2025-12-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07274800. Inclusion in this directory is not an endorsement.